Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,932,355
-
Total 13F shares
-
22,843,303
-
Share change
-
+1,934,781
-
Total reported value
-
$1,344,655,517
-
Put/Call ratio
-
64%
-
Price per share
-
$58.83
-
Number of holders
-
163
-
Value change
-
+$45,174,721
-
Number of buys
-
104
-
Number of sells
-
86
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q1 2020
As of 31 Mar 2020,
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) was held by
163 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,843,303 shares.
The largest 10 holders included
BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, IRIDIAN ASSET MANAGEMENT LLC/CT, RTW INVESTMENTS, LP, ALETHEA CAPITAL MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, VR Adviser, LLC, CITADEL ADVISORS LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
163
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.